Smith & Nephew PLC

Director's Dealing • Nov 12, 2025

National Storage Mechanism | Additional information

RNS Number : 2303H

Smith & Nephew Plc

12 November 2025

SMITH & NEPHEW PLC

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

VESTING OF RESTRICTED SHARE AWARD GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022 ("AWARD AGREEMENT")

On 11 November 2025, an award of 3,016 restricted shares granted to Deepak Nath under the Award Agreement vested and as set out below a number of the shares were sold to cover taxation obligations.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Vesting of Restricted Shares granted on 29 April 2022 under the Award Agreement and subsequent sell-to-cover transaction.
Date of Transaction	11 November 2025
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Status	Price (£)	Volume	Aggregated information
Deepak Nath (Chief Executive Officer)	Director	12.573092	3,016 (of which 1,240 shares were sold to cover taxes due and 1,776 shares were retained)	N/A Single Transaction

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel:  +44 (0)1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFFALVLFLIE